Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones Prelude Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances ALLY Q1 2026 Earnings EPS Beats Estimates by 1646 Stock Edges Up SPRY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues HRI Q1 2026 Earnings Significant EPS Beat Driven by Operational Improvements CREG Q1 2026 Earnings Loss per Share of 003 as Company Continues Strategic Transition